🇬🇧 Ch14.18 in United Kingdom

Ch14.18 (DINUTUXIMAB) regulatory status in United Kingdom.

Marketing authorisation

MHRA

  • Status: likely_approved

Ch14.18 in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Other Oncology approved in United Kingdom

Frequently asked questions

Is Ch14.18 approved in United Kingdom?

Yes. MHRA has authorised it.

Who is the marketing authorisation holder for Ch14.18 in United Kingdom?

United Therap is the originator. The local marketing authorisation holder may differ — check the official source linked above.